|
2022
|
Invention
|
Pharmaceutical composition comprising a potent inhibitor of urat1.
The present invention relates... |
|
2020
|
Invention
|
Thioacetate compounds, compositions and methods of use.
Described herein are compounds useful in... |
|
2019
|
Invention
|
Cxcr-2 inhibitors for treating disorders.
N-(6-(((2R,3S)-3,4-dihydroxy butan-2-yl)oxy)-2-((4-flu... |
|
|
Invention
|
Novel compounds and compositions and methods of use.
Described herein are compounds useful in th... |
|
2018
|
Invention
|
Polymorphic forms of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio)acetic... |
|
|
Invention
|
Thioacetate compounds, compositions and methods of use. Described herein are compounds useful in ... |
|
|
Invention
|
Treatment of gout and hyperuricemia.
Sodium 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4... |
|
|
Invention
|
Cxcr-2 inhibitors for treating disorders. N-(6-(((2R,3S)-3,4-dihydroxy butan-2-yl)oxy)-2-((4-fluo... |
|
|
Invention
|
3,4-di-substituted pyridine compound, methods of using and compositions comprising the same. 2-((... |
|
|
Invention
|
Methods for treating hyperuricemia and related diseases.
Provided herein are methods of treating... |
|
2017
|
Invention
|
Cxcr-2 inhibitors for treating crystal arthropathy disorders. N-(2-((2,3-difluorobenzyl)thio)-6-(... |
|
|
Invention
|
Atropisomers of triazole derivative.
Atropisomers of 2-(5-bromo-4-(4-cyclopropyl naphthalen-1-yl... |
|
|
Invention
|
Atropisomers of triazole derivative. Atropisomers of 2-(5-bromo-4-(4-cyclopropyl naphthalen-1-yl)... |
|
|
Invention
|
S-triazolyl alpha-mercapto acetanilides as inhibitors of hiv reverse transcriptase.
A series of ... |
|
2016
|
Invention
|
Pharmaceutical composition comprising a potent inhibitor of urat1. The present invention relates ... |
|
|
Invention
|
Compounds and compositions and methods of use. Described herein are compounds useful in the modul... |
|
|
Invention
|
Derivatives of n-(arylamino) sulfonamides as inhibitors of mek.
This invention concerns N-(2-ary... |
|
|
Invention
|
Treatment of gout.
Sodium 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4H-1,2,4-triazol-3-ylthio)... |
|
|
Invention
|
Manufacture of 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl)-4h-1,2,4-triazol-3-ylthio)acetic acid.... |
|
2015
|
Invention
|
Compounds, compositions and methods of using same for modulating uric acid levels.
Described her... |
|
|
Invention
|
Combinations of mek inhibitors and raf kinase inhibitors and uses thereof.
This invention concer... |
|
|
Invention
|
Phenylthioacetate compounds, compositions and methods of use.
Described herein are compounds use... |
|
2014
|
Invention
|
Preparation of (r)-n-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-dihydro... |
|
|
Invention
|
Polymorphic form of n-(s)-(3,4-difluoro-2-(2-fluoro-4-iodophenylamino)-6-methoxyphenyl)-1-(2,3-di... |
|
2013
|
Invention
|
Pharmaceutical combinations for treatment of specific cancers. The present invention relates to t... |
|
|
Invention
|
Polymorphic, crystalline and mesophase forms of sodium 2-(5-bromo-4-(4-cyclopropylnaphthalen-1-yl... |
|
|
Invention
|
Manufacture of 2- (5- bromo-4-(4-cyclopropylnaphthalen-1-yl) -4h-1,2,4-triazol-3-ylthio) acetic a... |
|
2012
|
Invention
|
Hypertension and hyperuricemia.
A method for treating hypertension in a subject in need thereof ... |
|
2007
|
G/S
|
Pharmaceutical preparations for use in the treatment of
viral diseases, cancer and inflammation.... |
|
|
G/S
|
Pharmaceutical preparations for use in the treatment of viral diseases, cancer and inflammation; ... |
|
|
G/S
|
Pharmaceutical preparations for use in the treatment of cancer, and inflammation. Pharmaceutical ... |
